Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (61-70 of 531) with videos related to

Pageof 54
Sort By:
Drug Intelligence & Clinical Pharmacy|November 1, 1986
Hematological effects associated with beta-lactam useL M Babiak, M J Rybak
Antimicrobial Agents and Chemotherapy|September 16, 1998
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methodsJ R Aeschlimann, M J Rybak
Pharmacotherapy|June 10, 1998
The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobialsL D Dresser, M J Rybak
Infectious Diseases and Therapy|September 13, 2015
Global Antimicrobial Stewardship: Challenges and Successes from Frontline StewardsDebra A Goff, Michael J Rybak
Pharmacotherapy|October 8, 1999
Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin familyD R Foster, M J Rybak
Clinical Pharmacy|November 1, 1983
Additive toxicity in patients receiving vancomycin and aminoglycosidesM J Rybak, S C Boike
The Journal of Antimicrobial Chemotherapy|April 1, 1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clotsS M Palmer, M J Rybak
The Journal of Antimicrobial Chemotherapy|November 6, 2008
Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetationsSteven N Leonard, Michael J Rybak
Pharmacotherapy|March 27, 2015
Efficacy of triclosan as an antimicrobial hand soap and its potential impact on antimicrobial resistance: a focused reviewChristopher A Giuliano, Michael J Rybak
The Journal of Comparative Neurology|August 9, 2001
Structure and response patterns of olfactory interneurons in the honeybee, Apis melliferaR Abel, J Rybak, R Menzel
Pageof 54

Showing results (61-70 of 531) with videos related to

Sort By:
Pageof 54
Drug Intelligence & Clinical Pharmacy|November 1, 1986
Hematological effects associated with beta-lactam useL M Babiak, M J Rybak
Antimicrobial Agents and Chemotherapy|September 16, 1998
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methodsJ R Aeschlimann, M J Rybak
Pharmacotherapy|June 10, 1998
The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobialsL D Dresser, M J Rybak
Infectious Diseases and Therapy|September 13, 2015
Global Antimicrobial Stewardship: Challenges and Successes from Frontline StewardsDebra A Goff, Michael J Rybak
Pharmacotherapy|October 8, 1999
Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin familyD R Foster, M J Rybak
Clinical Pharmacy|November 1, 1983
Additive toxicity in patients receiving vancomycin and aminoglycosidesM J Rybak, S C Boike
The Journal of Antimicrobial Chemotherapy|April 1, 1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clotsS M Palmer, M J Rybak
The Journal of Antimicrobial Chemotherapy|November 6, 2008
Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetationsSteven N Leonard, Michael J Rybak
Pharmacotherapy|March 27, 2015
Efficacy of triclosan as an antimicrobial hand soap and its potential impact on antimicrobial resistance: a focused reviewChristopher A Giuliano, Michael J Rybak
The Journal of Comparative Neurology|August 9, 2001
Structure and response patterns of olfactory interneurons in the honeybee, Apis melliferaR Abel, J Rybak, R Menzel
Pageof 54